5,628 reports of this reaction
2.4% of all BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE reports
#6 most reported adverse reaction
PNEUMONIA is the #6 most commonly reported adverse reaction for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, manufactured by AstraZeneca Pharmaceuticals LP. There are 5,628 FDA adverse event reports linking BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE to PNEUMONIA. This represents approximately 2.4% of all 236,943 adverse event reports for this drug.
Patients taking BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PNEUMONIA is a less commonly reported adverse event for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, but still significant enough to appear in the safety profile.
In addition to pneumonia, the following adverse reactions have been reported for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE:
The following drugs have also been linked to pneumonia in FDA adverse event reports:
PNEUMONIA has been reported as an adverse event in 5,628 FDA reports for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PNEUMONIA accounts for approximately 2.4% of all adverse event reports for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, making it a notable side effect.
If you experience pneumonia while taking BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.